Centene posts Q2 2025 loss of $0.51 per share vs. $2.16 profit a year earlier
Centene reported second quarter 2025 results in a press release furnished as Exhibit 99.1 to this 8-K. The company posted a GAAP diluted loss of $(0.51) per share, compared with diluted earnings of $2.16 per share a year earlier, driven primarily by a reduction in its net 2025 Marketplace risk adjustment revenue transfer estimate. Revenue grew while profit fell, and the company said it will provide 2025 earnings expectations on its July 25, 2025 conference call.
Key points
- GAAP diluted loss per share was $(0.51) versus $2.16 in Q2 2024; adjusted diluted loss per share was $(0.16) versus $2.42 a year earlier.
- Total revenues were $48.7 billion, up from $39.8 billion; premium and service revenues rose 18% to $42.5 billion.
- Health benefits ratio was 93.0% versus 87.6% in Q2 2024, mainly due to the lower Marketplace risk adjustment revenue estimate and higher Marketplace and Medicaid medical costs.
- Cash flow provided by operations was $1.8 billion, primarily driven by improved pharmacy rebate remittance timing.
The filing
Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 24, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.